Schenk, Erin L <br/><br/>
Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Oct 2012 
 - 5364-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-12-0961  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Apoptosis--drug effects<br/>Ataxia Telangiectasia Mutated Proteins<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Cycle Proteins--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Checkpoint Kinase 1<br/>Cytarabine--administration & dosage<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Protein Kinase Inhibitors--administration & dosage<br/>Protein Kinases--metabolism<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Pyrazoles--administration & dosage<br/>Pyrimidines--administration & dosage